The study confirmed the results from the authors cited previously; however, a completely different method was used. After the intervention, health status improved in both groups, but the significant differences between-groups postintervention were observed in favor for the intervention MT-C group. The research team identified large therapeutic effect sizes in the intervention group. The evidences show that the patients treated with MT-C reached clinically magnificent reducing pain on VAS, improvement of the quality of life on WOMAC, extension and flexion ROM, and functional capacity on 6-MWT. All the evidences allowed us to conclude that the MT-C is useful and indicates high efficacy for knee OA.